Final Programme - iuphar

FC13 Maximising benefits and minimizing harms from
drugs
Mon 349 An overview on attenuation of drug-induced nephrotoxicity
Guoying Cao, (PR China), X Hu
Mon 350 Pharmacological treatment of poststroke depression
Margarida Caramona, (Portugal), E Silva, B Oliveiros, E Ponciano
Mon 351 Thiopurine methyltransferase phenotype-genotype concordance in children with acute lymphoblastic
leukaemia
Cher Cartwright, (UK), C Mitchell, N Goulden, A Vora, L Lennard
Mon 352 A chemical genomics approach to cardiovascular therapeutics
Katherine Casey-Green, (UK), A Marsh, P Taylor, S Ladwa, W Dimitri, J Zhang, D Singer
Mon 353 Personalised therapies using a chemical genomics approach
Katherine Casey-Green, (UK), A Marsh, P Taylor, S Ladwa, W Dimitri, D Singer
Mon 354 Calcium channel is involved in neomycin-induced hair cell toxicity in the zebrafish lateral line
Ming-Huan Chan, (Taiwan), C-F Liu, H-H Chen
Mon 355 Bioequivalence study of two formulations of 35mg trimetazidine modified release tablets in Thai healthy
volunteers under fasting and fed conditions
Weerawadee Chandranipapongse, (Thailand), T Ruangnapa, S Ngokpol, K Sathirakul, P Pongnarin,
S Kongpatanakul
Mon 356 The effect of C825T polymorphism of the GNB3 gene on valproate-induced metabolic abnormalities in
bipolar disorder patients
Hui Hua Chang, (Taiwan), W Gean, YK Yang, HC Huang, HC Wang, RB Lu, PS Chen
Mon 357 Bioequivalence study of 10 mg ramipril tablets in healthy Thai volunteers
Somruedee Chatsiricharoenkul, (Thailand), W Thangboonjit, K Sathirakul, P Pongnarin, K Konhan,
S Kongpattanakul
Mon 358 Effects of CYP2D6*10 allele on the pharmacokinetics of atomoxetine in healthy Koreans
Chang-Ik Choi, (South Korea), J-W Bae, M-J Kim, C-G Jang, S-Y Lee
Mon 359 Dose adjustment of omeprazole based on CYP2C19 genotype
Chang-Ik Choi, (South Korea), S-M Moon, J-W Bae, M-J Kim, C-G Jang, S-Y Lee
Mon 360 Changing doctors prescription behaviour. A Drug Committee perspective: TNF inhibitors
Hanne R Christensen, (Denmark), H Thomsen
Mon 361 HPLC method development & validation for the determination of Warfarin in human plasma
Yung An Chua, (Malaysia), WZW Abdullah, SH Gan
Mon 362 High level of blood zolpidem concentrations in the morning and in the early afternoon after a single
dose of a hypnotic drug followed by a night of sleep in healthy elderly subjects: potential link with
impaired driving
Antoine Coquerel, (France), M Loilier, S Marie, F Bertran, V Lelong-Boulouard, P Denise, M-L Bocca
Mon 363 An enzyme-linked immunosorbent assay for therapeutic drug monitoring of trastuzumab
François Darrouzain, (France), I Teulon, T Ternant, D David, D Degenne, H Watier, P Gilles
Mon 364 Menatetrone and Nigella Sativa: a prophylactic role in corticosteroid induced osteoporosis in the rat
Suzan A Darwish, (Egypt), HM Khalifa, IE Darwish, EI Anwar
188 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area